STAT3 and Miyoshi myopathy: The IL-6/STAT3 signaling pathway is tightly controlled by the SOCS-1 protein, a negative regulator of cytokine signaling that is frequently inactivated by hypermethylation in MM patients, resulting in an uncontrolled IL-6 signaling [17].